4 Biotech Stocks with Bright Prospects in 2017

Biotech a happening but highly volatile sector again found itself in rough waters this year due to the drug pricing issue This is evident from the 20 8 decline witnessed by the NASDAQ Biotechnology Index in the year to date period Besides strained balance sheets and macroeconomic woes are